Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report) was up 7% on Monday . The company traded as high as $2.30 and last traded at $2.30. Approximately 400 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 3,367 shares. The stock had previously closed at $2.15.
Idorsia Stock Up 7.0 %
The firm has a fifty day simple moving average of $2.16 and a two-hundred day simple moving average of $2.12.
About Idorsia
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
See Also
- Five stocks we like better than Idorsia
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- 3 Best Fintech Stocks for a Portfolio Boost
- 3 Value Stocks You Can Buy Before They Become Big
- Why Are Stock Sectors Important to Successful Investing?
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.
